Pranali P. Deshpande

Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma

Aditi Jhaveri, Pranali P. Deshpande, Bhushan S. Pattni et al. · Journal of Controlled Release · 2018 · 281 citations · Full text

Nanomedicine, Neuro-oncology, Drug Targeting +6

Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo

Swati Biswas, Namita S. Dodwadkar, Pranali P. Deshpande et al. · Journal of Controlled Release · 2012 · 269 citations · Full text

Nanomedicine, Medicinal Chemistry, Polymer-drug Conjugate +8

Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery

Swati Biswas, Pranali P. Deshpande, Gemma Navarro et al. · Biomaterials · 2012 · 196 citations · Full text

Nanoparticles, Nanomedicine, Sirna Drug Co-delivery +7

Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer

Pranali P. Deshpande, Aditi Jhaveri, Bhushan S. Pattni et al. · Drug Delivery · 2018 · 110 citations · Full text

Octa-arginine-modified pegylated liposomal doxorubicin: An effective treatment strategy for non-small cell lung cancer

Swati Biswas, Pranali P. Deshpande, Federico Perche et al. · Cancer Letters · 2013 · 88 citations · Full text

Medicinal Chemistry, Polymer-drug Conjugate, Medicine +8